Headlines

GSK beefs up US manufacturing site with $800 million investment

The big pharma company GlaxoSmithKline will inject up to $800 million into its manufacturing site in Marietta, Pennsylvania, to double its size and capacity.

Rentschler Biopharma expands CDMO facilities in Germany

The expansion will involve the construction of a new buffer media facility and represents the largest investment from Rentschler at its Germany headquarters.

Paid for and content provided by METTLER TOLEDO

Achieving data integrity: Best practices for secure and reliable data management

In today's regulatory landscape, ensuring data integrity is crucial for compliance and process visibility. How can organizations enhance accuracy, consistency, and reliability?

Merck acquires cancer startup in a deal worth up to $1.3 billion

Merck’s acquisition of Modifi Biosciences will give it access to preclinical cancer drug candidates that target DNA repair processes.

Radiopharmaceutical CDMO launched by NorthStar Medical Radioisotopes

The US manufacturer NorthStar Medical Radioisotopes has unveiled a Contract Development & Manufacturing (CDMO) facility dedicated to the production and development of medical radioisotopes.

NICE rejects Donanemab for NHS use despite MHRA approval

Donanemab marks a significant advancement in Alzheimer’s treatment, but NHS patients face a setback with NICE's rejection of its cost-effectiveness.

PTC Therapeutics’ Translarna misses European regulatory hurdle again

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has once again snubbed Translarna (ataluren), PTC Therapeutics’ treatment for the genetic disease Duchenne muscular dystrophy (DMD).

Seaport Therapeutics closes $225 million Series B to develop neuropsychiatric drugs

The Boston-based biotech will use the new fundraise to develop its pipeline of drug candidates for conditions such as major depressive disorder and generalized anxiety disorder.